Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForesight Solar Fund Regulatory News (FSFL)

Share Price Information for Foresight Solar Fund (FSFL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 85.10
Bid: 85.10
Ask: 86.50
Change: -1.60 (-1.85%)
Spread: 1.40 (1.645%)
Open: 85.10
High: 85.10
Low: 85.10
Prev. Close: 86.70
FSFL Live PriceLast checked at -
Foresight Solar Fund is an Investment Trust

To provide investors with a sustainable, progressive quarterly dividend and enhanced capital value, through investment in ground based solar assets predominantly located in the UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of AGM

11 Jun 2018 16:33

RNS Number : 0245R
Foresight Solar Fund Limited
11 June 2018
 

11 June 2018

Foresight Solar Fund Limited

(the "Company")

Results of Annual General Meeting in accordance with LR 9.6.18

The Company is pleased to announce that, at the AGM held at 9:30 a.m. on Monday, 11 June 2018, each of the Resolutions were duly passed without amendment.

In accordance with LR 9.6.18, details of those resolutions passed are as follows:

In favour

(including discretionary)

Against Votes

Withheld*

Resolution

Votes

%

Votes

%

Votes

1

285,172,789

99.95

138,449

0.05

0

2

285,157,439

99.95

138,449

0.05

15,350

3

285,157,439

99.95

138,449

0.05

15,350

4

285,163,789

99.95

147,449

0.05

0

5

285,172,789

99.95

138,449

0.05

0

6

285,309,238

100.00

2,000

0.00

0

7

250,646,698

88.38

32,962,033

11.62

1,702,506

8

285,172,439

99.95

138,449

0.05

350

9

244,055,233

85.55

41,228,231

14.45

27,773

10

285,304,049

100.00

7,189

0.00

0

11

285,304,549

100.00

6,689

0.00

0

12

285,160,100

99.95

151,138

0.05

0

 

*A vote withheld is not a vote in law and is therefore not counted towards the proportion of votes "for" or "against" the Resolution.

 The full wording of these resolutions can be found below:-

 

Ordinary Resolutions

 

1) To receive and adopt the Company's annual accounts for the financial year ended 31 December 2017 together with the directors' report and auditors' report on those accounts.

 

2) To approve the directors' remuneration report (excluding the directors' remuneration policy, set out on page 49 of the directors' remuneration report), as set out in the Company's annual report and accounts for the financial year ended 31 December 2017.

 

3) To approve the directors' remuneration policy, as set out on page 49 of the directors' remuneration report, which takes effect immediately after the end of annual general meeting.

 

4) To re-appoint KPMG LLP as the Company's auditor to hold office from the conclusion of this meeting until the conclusion of the next annual general meeting at which accounts are laid before the Company.

 

5) To authorise the directors of the Company to determine the auditor's remuneration.

 

6) To approve the Dividend Policy.

 

7) To reappoint Alexander Ohlsson as a director of the Company.

 

8) To reappoint Chris Ambler as a director of the Company.

 

9) To reappoint Peter Dicks as a director of the Company.

 

Special Resolutions

 

10) THAT the Company be and is hereby generally and unconditionally authorised, pursuant to and in accordance with Article 57 of the Companies (Jersey) Law, 1991 (as amended) (the "Law") to make market purchases of its own ordinary shares of no par value in the capital of the Company (the "Ordinary Shares") on such terms and in such manner as the directors of the Company shall from time to time determine, subject always to the terms of any class rights in the articles of association and provided that:

 

a) the maximum aggregate number of Ordinary Shares hereby authorised to be purchased shall be such number as represents 14.99 per cent of the aggregate number of Ordinary Shares in issue as at 11 June 2018;

 

b) the minimum price which may be paid for an Ordinary Share shall be £0.01;

 

c) the maximum price exclusive of any expenses which may be paid for an Ordinary Share is an amount equal to the higher of (i) 105% of the average of the middle market quotations for an Ordinary Share (as derived from the Daily Official List of the London Stock Exchange plc) for the five business days immediately preceding the date on which such Ordinary Share is contracted to be purchased; and (ii) the higher of the last independent trade and the highest current independent bid on the trading venue on which the purchase is carried out.

 

d) the authority hereby conferred is in addition to all and any authorities in place in respect of market purchases by the Company and shall expire at the conclusion of the Company's next annual general meeting or on the date falling 18 months from the date of the passing of this resolution, whichever is earlier, unless previously revoked, varied or renewed by the Company in general meeting;

 

e) the Company may at any time prior to the expiry of such authority make a contract or contracts to purchase Ordinary Shares under such authority which will or might be completed or executed wholly or partly after the expiration of such authority and may make a purchase of Ordinary Shares in pursuance of any such contract or contracts; and

 

f) the directors of the Company provide a statement of solvency in accordance with the Articles 55 and 57 of the Law.

 

11) THAT, subject to resolution 10 ("Resolution 10") above being passed, the Company be and is hereby generally and unconditionally authorised to cancel any shares it repurchases pursuant to Resolution 10 or pursuant to Article 58A(1)(b) of the Law to hold such shares it repurchases pursuant to Resolution 10 as treasury shares to be dealt with in accordance with the provisions of the Law as the directors of the Company see fit.

 

12) THAT, in addition to any existing power and authority granted to the Directors, the Directors of the Company be and are hereby generally empowered to allot Ordinary Shares of no par value carrying the rights, privileges and subject to the restrictions attached to the Ordinary Shares as set out in the articles of association of the Company (the "Ordinary Shares") or to grant rights to subscribe for or, to convert securities into Ordinary Shares (''equity securities''), including the allotment and grant of rights to subscribe for, or to convert securities into or the sale of, Ordinary Shares held by the Company as treasury shares in each case for cash as if any pre-emption rights in relation to the issue of or sale of shares, as set out in Article 10.2 of the articles of association of the Company and in the Listing Rules made by the Financial Conduct Authority under Part VI of the Financial Services and Markets Act 2000 (as amended), did not apply to any such allotment of or grant of rights to subscribe for or to convert into equity securities or sale, provided that this power:

 

a) shall expire at the conclusion of the Company's next annual general meeting or on the date falling 15 months after the passing of this resolution, whichever is earlier, save that the Company may, before such expiry, make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Directors may allot equity securities in pursuance of any such offer or agreement as if the power conferred hereby had not expired; and

 

b) shall be limited to the allotment of up to 44,995,209 Ordinary Shares of no par value (representing as at 21 February 2018 approximately 10% per cent. of the issued share capital of the Company).

 

ENDS

 

For further information, please contact:

Foresight Group

Joanna Andrews

 

 +44 (0)20 3763 6951

 

 

Stifel Nicolaus Europe Limited

 +44 (0)20 7710 7660

Mark BloomfieldNeil Winward

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGLLFFERAILLIT
Date   Source Headline
26th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20245:00 pmRNSTransaction in Own Shares
22nd Apr 20245:15 pmRNSTransaction in Own Shares
19th Apr 20244:54 pmRNSTransaction in Own Shares
18th Apr 20245:00 pmRNSTransaction in Own Shares
17th Apr 20245:12 pmRNSTransaction in Own Shares
16th Apr 20245:39 pmRNSTransaction in Own Shares
15th Apr 20245:19 pmRNSTransaction in Own Shares
12th Apr 20245:00 pmRNSTransaction in Own Shares
11th Apr 20245:00 pmRNSTransaction in Own Shares
10th Apr 20245:03 pmRNSTransaction in Own Shares
9th Apr 20245:29 pmRNSTransaction in Own Shares
8th Apr 20245:05 pmRNSTransaction in Own Shares
5th Apr 20241:36 pmRNSHolding(s) in Company
4th Apr 20245:40 pmRNSTransaction in Own Shares
3rd Apr 20244:58 pmRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSAJ Bell ‘LIVE’ Investor Evening
2nd Apr 20244:53 pmRNSTransaction in Own Shares
28th Mar 20245:00 pmRNSTotal Voting Rights
28th Mar 20244:59 pmRNSTransaction in Own Shares
27th Mar 20243:52 pmRNSTransaction in Own Shares
27th Mar 20249:57 amRNSHolding(s) in Company
26th Mar 20244:55 pmRNSTransaction in Own Shares
25th Mar 20244:56 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSNotice of Capital Markets Event
22nd Mar 20244:57 pmRNSTransaction in Own Shares
21st Mar 20245:36 pmRNSTransaction in Own Shares
20th Mar 20244:59 pmRNSTransaction in Own Shares
19th Mar 20244:58 pmRNSTransaction in Own Shares
18th Mar 20245:10 pmRNSTransaction in Own Shares
15th Mar 20245:14 pmRNSTransaction in Own Shares
15th Mar 20244:24 pmRNSDirector/PDMR Shareholding
14th Mar 20245:14 pmRNSTransaction in Own Shares
14th Mar 20249:43 amEQSEdison issues flash on Foresight Solar Fund (FSFL): Optimising capital allocation
13th Mar 20245:49 pmRNSTransaction in Own Shares
12th Mar 20245:12 pmRNSTransaction in Own Shares
12th Mar 20247:00 amRNSAnnual Results to 31 December 2023
11th Mar 20244:33 pmRNSTransaction in Own Shares
8th Mar 20244:59 pmRNSTransaction in Own Shares
7th Mar 20245:02 pmRNSTransaction in Own Shares
6th Mar 20245:08 pmRNSTransaction in Own Shares
5th Mar 20244:55 pmRNSTransaction in Own Shares
4th Mar 20244:56 pmRNSTransaction in Own Shares
1st Mar 20245:06 pmRNSTransaction in Own Shares
1st Mar 20249:49 amRNSCorrection: Dividend Declaration
1st Mar 20247:00 amRNSDividend Declaration
29th Feb 20244:55 pmRNSTotal Voting Rights
29th Feb 20244:52 pmRNSTransaction in Own Shares
29th Feb 20243:19 pmRNSTransaction in Own Shares
23rd Feb 20245:09 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.